AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 14 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 3.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $6,027,000 | -17.1% | 9,517,000 | 0.0% | 0.04% | -27.4% |
| Q1 2018 | $7,273,000 | -3.9% | 9,517,000 | 0.0% | 0.06% | -6.1% |
| Q4 2017 | $7,566,000 | -0.1% | 9,517,000 | 0.0% | 0.07% | +8.2% |
| Q3 2017 | $7,576,000 | -34.4% | 9,517,000 | -34.4% | 0.06% | -39.6% |
| Q2 2017 | $11,549,000 | -12.8% | 14,517,000 | -12.1% | 0.10% | -6.5% |
| Q1 2017 | $13,241,000 | -30.7% | 16,517,000 | -37.7% | 0.11% | -42.2% |
| Q4 2016 | $19,103,000 | +9.6% | 26,517,000 | 0.0% | 0.19% | +18.4% |
| Q3 2016 | $17,432,000 | +17.5% | 26,517,000 | 0.0% | 0.16% | +1.3% |
| Q2 2016 | $14,840,000 | +9.7% | 26,517,000 | 0.0% | 0.16% | +9.1% |
| Q1 2016 | $13,526,000 | -22.9% | 26,517,000 | 0.0% | 0.14% | -1.4% |
| Q4 2015 | $17,552,000 | -11.7% | 26,517,000 | 0.0% | 0.14% | -21.2% |
| Q3 2015 | $19,873,000 | – | 26,517,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,500,000 | $1,219,000 | 0.82% |
| EdgePoint Investment Group Inc. | 51,642,000 | $41,704,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,600,000 | $13,359,000 | 0.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 43,150,000 | $34,952,000 | 0.52% |
| Tekla Capital Management LLC | 13,000,000 | $10,303,000 | 0.37% |
| UBS OCONNOR LLC | 26,000,000 | $20,669,000,000 | 0.30% |
| Orbimed Advisors | 15,000,000 | $12,151,000 | 0.12% |
| Baker Brothers Advisors | 9,517,000 | $7,576,000 | 0.06% |
| CSS LLC/IL | 653,000 | $517,000 | 0.02% |
| Allianz Asset Management GmbH | 28,680,000 | $23,232,000 | 0.02% |